LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors

Coronary artery disease (CAD) is the leading cause of death worldwide and is commonly caused by a constellation of risk factors called the metabolic syndrome. We characterized a family with autosomal dominant early CAD, features of the metabolic syndrome (hyperlipidemia, hypertension, and diabetes), and osteoporosis. These traits showed genetic linkage to a short segment of chromosome 12p, in which we identified a missense mutation in LRP6, which encodes a co-receptor in the Wnt signaling pathway. The mutation, which substitutes cysteine for arginine at a highly conserved residue of an epidermal growth factor–like domain, impairs Wnt signaling in vitro. These results link a single gene defect in Wnt signaling to CAD and multiple cardiovascular risk factors.

[1]  Gunnar von Heijne,et al.  Emulating Membrane Protein Evolution by Rational Design , 2007, Science.

[2]  Hussain Jafri,et al.  An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.

[3]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[4]  B. Franklin,et al.  Usefulness of bone mineral density to predict significant coronary artery disease. , 2005, The American journal of cardiology.

[5]  Matthias B. Wahl,et al.  Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis , 2004, Development.

[6]  Xi He,et al.  LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling: Arrows point the way , 2004, Development.

[7]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[8]  M. Ono,et al.  Severe Hypercholesterolemia, Impaired Fat Tolerance, and Advanced Atherosclerosis in Mice Lacking Both Low Density Lipoprotein Receptor-related Protein 5 and Apolipoprotein E* , 2003, The Journal of Biological Chemistry.

[9]  Masato Nose,et al.  Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Jensen-Urstad,et al.  Risk factors for coronary heart disease in 55‐ and 35‐year‐old men and women in Sweden and Estonia , 2002, Journal of internal medicine.

[11]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[12]  Joseph L. Goldstein,et al.  The Cholesterol Quartet , 2001, Science.

[13]  Yan Li,et al.  LDL-receptor-related protein 6 is a receptor for Dickkopf proteins , 2001, Nature.

[14]  P. Poulsen,et al.  Genetic versus environmental aetiology of the metabolic syndrome among male and female twins , 2001, Diabetologia.

[15]  H. Tunstall-Pedoe,et al.  Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations , 2000, The Lancet.

[16]  E R Levy,et al.  Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. , 1998, Biochemical and biophysical research communications.

[17]  Hiroyuki Kuroki,et al.  Mutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY , 1997, Nature Genetics.

[18]  N. Risch,et al.  Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21 , 1997, Nature Genetics.

[19]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[20]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[21]  S. Grundy,et al.  National Cholesterol Education Program, second report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. , 1995 .

[22]  L. Berkman,et al.  Genetic susceptibility to death from coronary heart disease in a study of twins. , 1994, The New England journal of medicine.

[23]  G. Reaven,et al.  Insulin-resistance and associated risk factors for coronary heart disease as seen in families. , 1991, Diabete & metabolisme.

[24]  W. Kannel,et al.  Coronary risk associated with age and sex of parental heart disease in the Framingham Study. , 1989, The American journal of cardiology.

[25]  W. Kimberling,et al.  Genetic–Epidemiologic Study of Early–onset Ischemic Heart Disease , 1980, Circulation.

[26]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[27]  J. Ashby.  References and Notes , 1999 .

[28]  M. Stoffel,et al.  Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1996, Nature.